Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Nucynta ER

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 583Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Humanwell’s Generics Tapentadol HCl Receives Approval in US
    Humanwell’s Generics Tapentadol HCl Receives Approval in US

    27 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214378

    FDA
    27 Jan 2026
    Share Share
    Novitium Pharma’s Generics Tapentadol HCl Receives Approval in US
    Novitium Pharma’s Generics Tapentadol HCl Receives Approval in US

    26 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219119

    FDA
    26 Jan 2026
    Share Share
    Haryana FDA Seizes Tapentadol And Pregabalin Stock In Sirsa
    Haryana FDA Seizes Tapentadol And Pregabalin Stock In Sirsa

    22 Jan 2026

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=183693&sid=1

    PHARMABIZ
    22 Jan 2026
    Share Share
    Delhi DCA Warns Chemists on Misuse of Pregabalin, Tapentadol
    Delhi DCA Warns Chemists on Misuse of Pregabalin, Tapentadol

    19 Aug 2025

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=180763&sid=1

    PHARMABIZ
    19 Aug 2025
    Share Share
    Haryana Officials Ramp Up Illicit Drug Trade Crackdown in Sirsa
    Haryana Officials Ramp Up Illicit Drug Trade Crackdown in Sirsa

    13 Aug 2025

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=180671&sid=1

    PHARMABIZ
    13 Aug 2025
    Share Share
    Tapentadol may be classified under Narcotics Act to limit access
    Tapentadol may be classified under Narcotics Act to limit access

    02 May 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/opioid-tapentadol-may-be-put-under-narcotics-act-to-curb-its-access/articleshow/120802372.cms

    ECONOMICTIMES
    02 May 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.